These protein markers alongside relevant metabolites of the KP pathway, AA, ADPR, and cADPR signify a collection of indicators of immune disruption applicable to tissue, serum and nasal swab sampling relevant for immune triggered diseases in both COVID-19 and IBD. The gene discussed is NPPA; the disease is irritable bowel syndrome.